延长哀伤障碍的特异性认知行为治疗:随机对照试验研究方案
本研究为多中心随机对照试验,纳入204例以延长哀伤障碍(PGD)为主要诊断的成人,比较新开发的延长哀伤特异性整合认知行为治疗(PG-CBT)与主动非特异性治疗——现时中心治疗(PCT)。两种治疗均包含20至24次个体会话,总疗程约6个月。主要结局为随机化后12个月由盲法访谈评估的哀伤症状严重程度,假设PG-CBT优于PCT。
要点
- PG-CBT与PCT均设置20–24次个体会话,总疗程约6个月。
- 主要结局为随机化后12个月盲法访谈评估的哀伤症状严重程度。
- 试验采用分层随机化、盲法评估、意向性分析等措施减少偏倚。
核心结论
- 试验旨在评估PG-CBT相比PCT对延长哀伤障碍的疗效,假设PG-CBT更优。
研究设计与样本
- 多中心随机对照试验,纳入204例以延长哀伤障碍为主要诊断的成人。
- PG-CBT与PCT均为20至24次个体会话,总疗程约6个月。
主要发现
- 主要结局为随机化后12个月盲法访谈评估的哀伤症状严重程度。
- 次要结局包括治疗后哀伤症状严重程度,以及治疗后和随机化后12个月自报总体心理健康症状、抑郁和躯体症状。
局限性
- 次要分析(包括调节因素分析)本质上是探索性的。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prolonged grief disorder (PGD) has emerged as a well-defined and relatively common mental disorder that will be included in the upcoming revision of the International Classification of Diseases. Recent trials with grief-specific, mostly cognitive behavioral interventions for patients with a clinically relevant diagnosis of PGD showed large effect sizes. However, a small trial suggested that non-specific behavioral activation might suffice to improve PGD. So, more evidence for the relative efficacy of grief-specific treatments is needed, as is more research on the predictors of treatment success. The purpose of the proposed trial is to evaluate a newly developed and successfully pilot-tested, prolonged grief-specific, integrative cognitive behavioral therapy (PG-CBT) compared to an active yet unspecific treatment, present-centered therapy (PCT). METHODS: In a multicenter, randomized controlled trial with 204 adults with a primary diagnosis of PGD, PG-CBT is compared to PCT, assuming the superiority of PG-CBT. Both treatments consist of 20 to 24 individual sessions, with an overall treatment length of about 6 months. The primary outcome, grief symptom severity, is assessed by blinded interviewers 12 months after randomization. Secondary outcomes are grief symptom severity at post treatment, in addition to self-reported overall mental health symptoms, depressive and somatoform symptoms at post treatment and 12 months post randomization. Possible moderators and mediators of treatment success are also explored. DISCUSSION: The trial is designed to avoid bias as much as possible (stratified randomization performed independently, blinded outcome assessment, intention-to-treat-analysis, balanced treatment dose, continuous supervision, control for allegiance effects) thereby enhancing internal validity. At the same time, some aspects of the trial will ensure clinical relevance (recruiting at outpatient clinics that are part of routine health care and keeping exclusion criteria to a minimum). Since the trial is powered adequately for the primary outcome, all secondary analyses including moderator analyses are exploratory by nature. The results will extend the knowledge on efficacious treatment of PGD and its predictors. TRIAL REGISTRATION: German Clinical Trials Register, ID: DRKS00012317 . Registered on 6 September 2017.
引用
- Rosner R, Rimane E, Vogel A, et al. Treating prolonged grief disorder with prolonged grief-specific cognitive behavioral therapy: study protocol for a randomized controlled trial. Trials. 2018. PMID: 29678193. doi:10.1186/s13063-018-2618-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。